Abbott Laboratories (ABT): CFO sold ~$747K

~$747K

Approx. value · 5,550 sh @ $134.55

51K

Holds after · shares reported

Traded

Aug 8, 2025

Filed

Aug 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 15, 2023CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
2. May 12, 2025CongressDisclosed sale of ABT — reported range $50,001 - $100,000
3. Jun 24, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
4. Jul 10, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
5. Jul 18, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
6. Jul 21, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
7. Aug 8, 2025 · this disclosureInsiderCFO sold ~$747K of ABT shares in the open market

What came next

1. Aug 14, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
2. Sep 10, 2025FDARecall: TactiFlex Sensor Enabled Ablation Catheter, 8F, 115 cm, FJ, (BiD Curve F-J), REF A-TFSE-FJ; cardiac catheter
3. Sep 10, 2025FDARecall: TactiFlex Sensor Enabled Ablation Catheter, 8F, 115 cm, DD, (BiD Curve D-D), REF A-TFSE-DD; cardiac catheter
4. Sep 17, 2025FDAFDA device clearance: Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000)
5. Sep 18, 2025FDARecall: Brand Name: Alinity hq Analyzer Product Name: Alinity hq Analyzer Model/Catalog Number: 09P68-01 Software Version: 5.0 to 5.10.1 for OUS, 5.7 and 5.10.1 in the…
6. Sep 25, 2025FDAFDA device clearance: Alinity m HCV
7. Sep 25, 2025FDAFDA device clearance: EnSite™ X EP System
8. Oct 3, 2025FDAFDA device clearance: Amplatzer Guidewire
9. Oct 6, 2025FDARecall: Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400
10. Oct 6, 2025FDARecall: Liberta RC DBS IPG (Implantable Pulse Generator), Model Number 62400
11. Oct 6, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
12. Oct 15, 2025Company filing · Form 8-K · ResultsReported its results
13. Oct 29, 2025FDAFDA device clearance: Seguin Annuloplasty Ring
14. Nov 13, 2025FDARecall: Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20
15. Nov 18, 2025Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit PlansSuspended trading under its employee plans
16. Nov 19, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
17. Nov 24, 2025FDARecall: FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI code: 00357599818005 The FreeStyle Libre 3 sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monit…
18. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 78768-01 UDI-DI code: 00357599844011 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
19. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 78769-01 UDI-DI code: 00357599843014 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
20. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 72080-01 UDI-DI code: 00357599819002 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 6 Congress trade reports and 59 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Philip P Boudreau, EVP AND CFO

• SEC Form 4 at Abbott Laboratories (ABT)Apr 27, 2026

The full history of Philip P Boudreau, EVP AND CFO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Abbott Laboratories

• House Clerk periodic transaction reportOct 30, 2026
• House Clerk periodic transaction reportOct 27, 2026
• House Clerk periodic transaction reportOct 12, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 144Sep 2, 2026
• SEC Form 4Aug 27, 2026

Everything OQRO holds on this company is on its ABT page.